Equioxx (Firocoxib (equine)) is filed as COX-2 selective NSAID. The sections below restate public label fields stored for this profile.
Control of pain and inflammation associated with osteoarthritis in horses
Selectively inhibits cyclooxygenase-2 (COX-2), reducing inflammation while sparing COX-1-mediated protective GI and renal functions.
Do not use with other NSAIDs or corticosteroids. Monitor for GI, renal, and hepatic effects. Not for food-producing horses.
Specific contraindication data for this veterinary product may not be available in public databases. Consult your veterinarian before use.
Oral/GI erosions (Occasional); Weight loss with prolonged use (Occasional); Renal effects (Rare)
Oral paste: 0.1 mg/kg once daily for up to 14 days. Injectable: single IV dose.
Limited structured drug interaction data is available from public sources for this veterinary product. Consult your veterinarian about potential interactions with other medications.
According to its FDA label, Equioxx (Firocoxib (equine)) is approved for: Control of pain and inflammation associated with osteoarthritis in horses For medical advice, please talk to your prescriber or pharmacist.
Equioxx (Firocoxib (equine)) belongs to the COX-2 selective NSAID class of medications.
Not yet. As of the most recent FDA data we ingest, no A-rated generic equivalent is listed for Equioxx. Availability changes as patents expire.
Our ingest of the FDA label for Equioxx (Firocoxib (equine)) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.
Public CMS NADAC pricing for Equioxx (Firocoxib (equine)) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.
The FDA Enforcement Report does not show an active/ongoing recall for Equioxx (Firocoxib (equine)) in our latest ingest. Recall data can change daily — verify at FDA.gov.
The FDA label lists Boehringer Ingelheim as a labeler/manufacturer of Equioxx (Firocoxib (equine)). Multiple firms may market generics of the same molecule.
The FDA label states: "Store at controlled room temperature." Follow the packaging insert for the authoritative guidance.
Loading full data from Know Your Drugs Institute…